Author of

• 20189

  +

  P3.10 - Nursing/Palliative Care/Ethics (ID 726)

  • Event: WCLC 2017
  • Type: Poster Session with Presenters Present
  • Track: Nursing/Palliative Care/Ethics
  • Presentations: 1
  • Moderators:
  • Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)

  • 24140

    +

    P3.10-002 - Implementing an Innovative Distress/Supportive Care Screening Tool in a Lung Cancer Clinic (ID 10228)

    09:30 - 09:30  |  Author(s): S. Obilade
    • Abstract

    Background:
    The Institute of Medicine (IOM) 2013 report recommends that supportive oncology care start at cancer diagnosis; the Commission on Cancer (CoC) Standard 3.2 requires distress screening and indicated action. The Coleman Supportive Oncology Collaborative “Patient Screening Questions for Supportive Care” tool was used to investigate the relationships between demographic/diagnostic data and screening scores.
    
    Method:
    Lung cancer patients at the University of Illinois Cancer Center were screened using the following Coleman Foundation tool shown below: Figure 1 Data was collected on an Excel spreadsheet and statistically analyzed.
    
    
    
    Result:
    We performed initial screening on 138 lung cancer patients. Demographics are shown in table below: Figure 1 Statistically signifcant correlations were found with the following: --Gender and racial/ethnic minority status correlated with distress/concerns over diagnosis and treatment. --Type of medical insurance correlated with distress/concerns over nutrition (food insecurity) and physical activity.
    
    
    
    Conclusion:
    Introduction of distress screening tool facilitated identification of some care needs such as patient education and counseling, nutrition services, and physical therapy. Moreover certain demographic groups have especially high burdens in some specific patient concern areas. Our next step is to expand distress screening to determine longitudinal trends, expand supportive oncology services to meet our patients’ needs, and to assess impact on unplanned ED visits and patient outcomes.